BidaskClub upgraded shares of NantHealth (NASDAQ:NH) from a sell rating to a hold rating in a report published on Tuesday.
Several other analysts also recently commented on NH. Zacks Investment Research upgraded NantHealth from a hold rating to a buy rating and set a $4.25 target price on the stock in a research note on Thursday, January 11th. Jefferies Group reiterated a buy rating and set a $5.00 target price on shares of NantHealth in a research note on Thursday, September 28th. Finally, Canaccord Genuity cut their target price on NantHealth from $6.00 to $5.00 and set a buy rating on the stock in a research note on Friday, November 17th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The company currently has a consensus rating of Buy and a consensus target price of $8.05.
NantHealth (NASDAQ:NH) traded up $0.18 during trading on Tuesday, hitting $3.95. The company had a trading volume of 526,800 shares, compared to its average volume of 225,050. The company has a debt-to-equity ratio of 0.93, a current ratio of 2.38 and a quick ratio of 2.36. The stock has a market cap of $408.40, a P/E ratio of -2.22 and a beta of -1.50. NantHealth has a 52 week low of $2.60 and a 52 week high of $10.02.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in NH. Bank of New York Mellon Corp lifted its holdings in shares of NantHealth by 194.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 44,849 shares of the company’s stock valued at $190,000 after buying an additional 29,639 shares during the period. Alliancebernstein L.P. bought a new position in shares of NantHealth during the 2nd quarter valued at $102,000. Teachers Advisors LLC lifted its holdings in shares of NantHealth by 351.8% during the 2nd quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock valued at $134,000 after buying an additional 24,588 shares during the period. TIAA CREF Investment Management LLC lifted its holdings in shares of NantHealth by 136.9% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 47,848 shares of the company’s stock valued at $202,000 after buying an additional 27,648 shares during the period. Finally, GSA Capital Partners LLP bought a new position in shares of NantHealth during the 2nd quarter valued at $121,000. 7.10% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This story was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3142745/nanthealth-nh-rating-increased-to-hold-at-bidaskclub.html.
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.